Patent protection and patient access should be balanced

The excessive patent protection should be avoided as it may discourage the development of any innovative medicines as well as patient access, according to Park Sylvia a chief researcher at the Korea Institute for Health and Social Affairs.

“When drug companies innovate new drugs which benefit the patient, they are indeed preventing disease and saving lives. And they should be rewarded for do...